DI GIORGIO, Eros
DI GIORGIO, Eros
DMED - DIPARTIMENTO DI MEDICINA
A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory Cells
2021-01-01 Di Giorgio, E.; Wang, L.; Xiong, Y.; Christensen, L. M.; Akimova, T.; Han, R.; Samanta, A.; Trevisanut, M.; Brancolini, C.; Beier, U. H.; Hancock, W. W.
A regulative epigenetic circuit supervised by HDAC7 represses IGFBP6 and IGFBP7 expression to sustain mammary stemness
2021-01-01 Di Giorgio, E.; Cutano, V.; Minisini, M.; Tolotto, V.; Dalla, E.; Brancolini, C.
Beside the MEF2 axis: Unconventional functions of HDAC4.
2013-01-01 Clocchiatti, A; DI Giorgio, E; Demarchi, F; Brancolini, Claudio
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids
2024-01-01 Gagliano, Teresa; Kerschbamer, Emanuela; Baccarani, Umberto; Minisini, Martina; Di Giorgio, Eros; Dalla, Emiliano; Weichenberger, Christian X; Cherichi, Vittorio; Terrosu, Giovanni; Brancolini, Claudio
Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors.
2013-01-01 Clocchiatti, A; Di Giorgio, E; Ingrao, S; Meyer Almes, Fj; Tripodo, C; Brancolini, Claudio
Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy
2022-01-01 Renzini, A.; Marroncelli, N.; Cavioli, G.; Di Francescantonio, S.; Forcina, L.; Lambridis, A.; Di Giorgio, E.; Valente, S.; Mai, A.; Brancolini, C.; Giampietri, C.; Magenta, A.; De Santa, F.; Adamo, S.; Coletti, D.; Moresi, V.
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
2020-01-01 Di Giorgio, E.; Dalla, E.; Franforte, E.; Paluvai, H.; Minisini, M.; Trevisanut, M.; Picco, R.; Brancolini, C.
Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells
2023-01-01 Di Giorgio, E.; Ferino, A.; Huang, W.; Simonetti, S.; Xodo, L.; De Marco, R.
Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression?
2022-01-01 DI GIORGIO, Eros
Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo
2021-01-01 Iuliano, L.; Drioli, S.; Pignochino, Y.; Cafiero, C. M.; Minisini, M.; D'Este, F.; Picco, R.; Dalla, E.; Giordano, G.; Grignani, G.; Di Giorgio, E.; Benedetti, F.; Felluga, F.; Brancolini, C.
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study
2023-01-01 Xodo, S.; Celante, L.; Liviero, S.; Orsaria, M.; Mariuzzi, L.; De Luca, M.; Damante, G.; Driul, L.; Cagnacci, A.; Ferino, A.; Di Giorgio, E.; Xodo, L.; Londero, A. P.
Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA
2024-01-01 Chinellato, M.; Perin, S.; Carli, A.; Lastella, L.; Biondi, B.; Borsato, G.; Di Giorgio, E.; Brancolini, C.; Cendron, L.; Angelini, A.
Genetic programs driving oncogenic transformation: Lessons from in vitro models
2019-01-01 Di Giorgio, E.; Paluvai, H.; Picco, R.; Brancolini, C.
GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ
2020-01-01 Ciotti, S.; Iuliano, L.; Cefalu, S.; Comelli, M.; Mavelli, I.; Di Giorgio, E.; Brancolini, C.
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers
2021-01-01 Di Giorgio, E.; Paluvai, H.; Dalla, E.; Ranzino, L.; Renzini, A.; Moresi, V.; Minisini, M.; Picco, R.; Brancolini, C.
HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repair
2024-01-01 Di Giorgio, E.; Dalla, E.; Tolotto, V.; D'Este, F.; Paluvai, H.; Ranzino, L.; Brancolini, C.
HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
2019-01-01 Cutano, V.; Di Giorgio, E.; Minisini, Martina; Picco, R.; Dalla, E.; Brancolini, C.
Inhibiting the coregulator CoREST impairs Foxp3+ Treg function and promotes antitumor immunity
2020-01-01 Xiong, Y.; Wang, L.; Giorgio, E. D.; Akimova, T.; Beier, U. H.; Han, R.; Trevisanut, M.; Kalin, J. H.; Cole, P. A.; Hancock, W. W.
MEF2 and the tumorigenic process, hic sunt leones
2018-01-01 Di Giorgio, Eros; Hancock, Wayne W.; Brancolini, Claudio
MEF2 is a converging hub for HDAC4 and PI3K/Akt-induced transformation.
2013-01-01 Di Giorgio, E; Clocchiatti, A; Piccinin, S; Sgorbissa, A; Viviani, G; Peruzzo, P; Romeo, S; Rossi, S; Dei Tos, Ap; Maestro, R; Brancolini, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory Cells | 1-gen-2021 | Di Giorgio, E.; Wang, L.; Xiong, Y.; Christensen, L. M.; Akimova, T.; Han, R.; Samanta, A.; Trevisanut, M.; Brancolini, C.; Beier, U. H.; Hancock, W. W. | |
| A regulative epigenetic circuit supervised by HDAC7 represses IGFBP6 and IGFBP7 expression to sustain mammary stemness | 1-gen-2021 | Di Giorgio, E.; Cutano, V.; Minisini, M.; Tolotto, V.; Dalla, E.; Brancolini, C. | |
| Beside the MEF2 axis: Unconventional functions of HDAC4. | 1-gen-2013 | Clocchiatti, A; DI Giorgio, E; Demarchi, F; Brancolini, Claudio | |
| Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids | 1-gen-2024 | Gagliano, Teresa; Kerschbamer, Emanuela; Baccarani, Umberto; Minisini, Martina; Di Giorgio, Eros; Dalla, Emiliano; Weichenberger, Christian X; Cherichi, Vittorio; Terrosu, Giovanni; Brancolini, Claudio | |
| Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors. | 1-gen-2013 | Clocchiatti, A; Di Giorgio, E; Ingrao, S; Meyer Almes, Fj; Tripodo, C; Brancolini, Claudio | |
| Cytoplasmic HDAC4 regulates the membrane repair mechanism in Duchenne muscular dystrophy | 1-gen-2022 | Renzini, A.; Marroncelli, N.; Cavioli, G.; Di Francescantonio, S.; Forcina, L.; Lambridis, A.; Di Giorgio, E.; Valente, S.; Mai, A.; Brancolini, C.; Giampietri, C.; Magenta, A.; De Santa, F.; Adamo, S.; Coletti, D.; Moresi, V. | |
| Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells | 1-gen-2020 | Di Giorgio, E.; Dalla, E.; Franforte, E.; Paluvai, H.; Minisini, M.; Trevisanut, M.; Picco, R.; Brancolini, C. | |
| Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells | 1-gen-2023 | Di Giorgio, E.; Ferino, A.; Huang, W.; Simonetti, S.; Xodo, L.; De Marco, R. | |
| Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression? | 1-gen-2022 | DI GIORGIO, Eros | |
| Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo | 1-gen-2021 | Iuliano, L.; Drioli, S.; Pignochino, Y.; Cafiero, C. M.; Minisini, M.; D'Este, F.; Picco, R.; Dalla, E.; Giordano, G.; Grignani, G.; Di Giorgio, E.; Benedetti, F.; Felluga, F.; Brancolini, C. | |
| Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study | 1-gen-2023 | Xodo, S.; Celante, L.; Liviero, S.; Orsaria, M.; Mariuzzi, L.; De Luca, M.; Damante, G.; Driul, L.; Cagnacci, A.; Ferino, A.; Di Giorgio, E.; Xodo, L.; Londero, A. P. | |
| Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA | 1-gen-2024 | Chinellato, M.; Perin, S.; Carli, A.; Lastella, L.; Biondi, B.; Borsato, G.; Di Giorgio, E.; Brancolini, C.; Cendron, L.; Angelini, A. | |
| Genetic programs driving oncogenic transformation: Lessons from in vitro models | 1-gen-2019 | Di Giorgio, E.; Paluvai, H.; Picco, R.; Brancolini, C. | |
| GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ | 1-gen-2020 | Ciotti, S.; Iuliano, L.; Cefalu, S.; Comelli, M.; Mavelli, I.; Di Giorgio, E.; Brancolini, C. | |
| HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers | 1-gen-2021 | Di Giorgio, E.; Paluvai, H.; Dalla, E.; Ranzino, L.; Renzini, A.; Moresi, V.; Minisini, M.; Picco, R.; Brancolini, C. | |
| HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repair | 1-gen-2024 | Di Giorgio, E.; Dalla, E.; Tolotto, V.; D'Este, F.; Paluvai, H.; Ranzino, L.; Brancolini, C. | |
| HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells | 1-gen-2019 | Cutano, V.; Di Giorgio, E.; Minisini, Martina; Picco, R.; Dalla, E.; Brancolini, C. | |
| Inhibiting the coregulator CoREST impairs Foxp3+ Treg function and promotes antitumor immunity | 1-gen-2020 | Xiong, Y.; Wang, L.; Giorgio, E. D.; Akimova, T.; Beier, U. H.; Han, R.; Trevisanut, M.; Kalin, J. H.; Cole, P. A.; Hancock, W. W. | |
| MEF2 and the tumorigenic process, hic sunt leones | 1-gen-2018 | Di Giorgio, Eros; Hancock, Wayne W.; Brancolini, Claudio | |
| MEF2 is a converging hub for HDAC4 and PI3K/Akt-induced transformation. | 1-gen-2013 | Di Giorgio, E; Clocchiatti, A; Piccinin, S; Sgorbissa, A; Viviani, G; Peruzzo, P; Romeo, S; Rossi, S; Dei Tos, Ap; Maestro, R; Brancolini, Claudio |